Canadian Association of Neuroscience Nurses - CANN Nova Scotia Chapter

01/09/2026

Abstract submissions close in 10 days!!!

CANNmore 2026 conference call for abstracts deadline is 10 days away! Need more info? Visit https://cannmore2026.dryfta.com/

01/08/2026

🧠😴 The Migraine Connection: Sleep & Mental Health (Part 1)

Poor sleep can trigger migraine. Migraine can disrupt sleep. Mental health weaves through both.

Join Dr. Michael Mak, MD, FRCPC, FAASM as he explores:
• The role of sleep in migraine
• Common sleep disorders (insomnia, sleep apnea, circadian disruptions)
• The two-way link between migraine and mental health
• Why treating one can help improve the others

📅 Wednesday, January 14
⏰ 7:30 PM ET
🎓 Free webinar | Registration required

Register now: 0e2e0f8f-0435-49d5-a195-4fbac012e1bb@1751f303-4d61-4c06-b925-154ac230edec" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/0e2e0f8f-0435-49d5-a195-4fbac012e1bb@1751f303-4d61-4c06-b925-154ac230edec

01/08/2026

Feeling lucky? Buy a square and support your vibrant neuro community! $10 per square - pick your lucky number for the chance to win $500. Accepting cash or e-transfer to cann.novascotia@gmail.com. Good luck!!! A winner will be drawn when the board is full. Thank you :)
36/100 squares sold!

11/25/2025

CANNmore 2026 Abstract Submission portal is OPEN! 👏

https://cannmore2026.dryfta.com/72-abstract-submission

The Scientific Committee welcomes the submission of abstracts on any neuroscience nursing topic including: clinical practice, research, education, and policy. Submissions from Allied Health Professionals are also welcomed. This is an excellent opportunity to showcase your work, network with peers, and contribute to the advancement of neuroscience health services.

Conference Topics /Ideas:

Neuro Disorders

Neurocritical Care

Neurorehabilitation

Neuroscience Research (includes student capstone projects, theses, and dissertations)

Quality Improvement Projects

Advanced Practice in Neuroscience Nursing

Emerging Issues in Neuroscience Nursing

Leadership and Professional Development in Neurosciences

Presentation Formats:

Oral Presentation: Plenary (45 minutes+10 minutes for questions)
Oral Presentation: Concurrent Session (20 minutes +5 minutes for questions)

Oral Presentation: Pecha Kucha (6 mins 40 seconds +2 mins for questions)

Workshop (45 to 90 minutes)

Digital Poster (time slots for presentation/Q&A will be determined based on number of submissions)

Creative Arts: Visual media, Dance, Music, Poetry, etc. (5 to 15 minutes)

11/25/2025

11/25/2025

Promising new treatments for multiple sclerosis (MS) are on the horizon - and The Neuro’s Clinical Research Unit is helping bring them closer.

“The majority of patients diagnosed today will live without new attacks or new lesions on their brain or spinal cord. That is very different from a patient’s experience just a decade ago.” – Dr. Adil Harroud, who is leading clinical trials exploring therapies that could ease difficult MS symptoms and improve long-term disease management.

Harroud is currently leading two innovative clinical trials: one testing an eye-tracking app to detect early changes in brain function, and another investigating a novel therapy to ease spasticity, a common and challenging MS symptom.

🧠 Learn more about what’s next in MS research: https://cru.mcgill.ca/advances-ms/
📧 For more information about current trials: https://cru.mcgill.ca/trials/

-------

De nouveaux traitements prometteurs pour la sclérose en plaques (SP) se profilent à l’horizon — et l’Unité de recherche clinique du Neuro () contribue à les rapprocher.

« La majorité des patients diagnostiqués aujourd’hui vivront sans nouvelles poussées ni nouvelles lésions au cerveau ou à la moelle épinière. C’est très différent de l’expérience des patients d’il y a seulement dix ans. » – Dr Adil Harroud, qui dirige des essais cliniques sur des thérapies visant à soulager les symptômes difficiles de la SP et à améliorer la gestion à long terme de la maladie.

Le Dr Harroud mène actuellement deux essais cliniques novateurs : l’un teste une application de suivi oculaire pour détecter précocement des changements dans le fonctionnement du cerveau, et l’autre évalue une nouvelle thérapie visant à réduire la spasticité, un symptôme fréquent et difficile de la SP.

🧠 Pour en savoir plus sur les prochaines avancées de la recherche sur la SP : https://cru.mcgill.ca/fr/avancees-sp/

McGill University McGill Faculty of Medicine and Health Sciences Centre universitaire de santé McGill - McGill University Health Centre MS Canada

11/25/2025

The CANN Board of Directors got together for our first Quarterly Board Meeting last weekend. Meaningful and exciting conversations were had about CANN's plans for the year and beyond in alignment with CANN Strategic Plan.

Join CANN today and stay tuned for updates from your Probincial Councillors and CANN National! 🧠 🩺

11/25/2025

The Virtual International Neuroscience Nursing Research Symposium (INNRS) will be held on Friday, January 23, 2026, and you’re invited to connect with neuroscience nurses from around the world!
Hosted by , this virtual event is your chance to connect, learn, and lead in neuroscience nursing, no matter where you are in the world.
Earn up to 7 CE contact hours from interactive discussions and moderated Q&A sessions.
Register now at https://apps.aann.org/meeting?ProductId=1079612856

11/25/2025

Analysis of Factors and Clinical Outcomes of Planned Tracheal Extubation Failure in Neurosurgical Intensive Care Unit PatientsPlanned tracheal extubation fai...

10/29/2025

10/29/2025

10/29/2025

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.